She was awarded the prestigious Infosys Prize in Life Sciences in 2016 for her contributions to understanding the natural history of rotavirus and other infectious diseases.
[10] Kang is co-author of book Till We Win: India's Fight Against The COVID-19 Pandemic, with Chandrakant Lahariya, a leading Indian medical doctor and Public policy and health system expert and Randeep Guleria, the director of AIIMS, New Delhi.
Kang is a medical scientist who has worked on diarrhea diseases and public health in India since the early 1990s.
Focusing on vaccines, enteric infections and nutrition in young children in disadvantaged communities, she has combined field epidemiology with intensive laboratory investigations to inform both the science of infectious diseases and policy in India.
[13] Kang played a significant role in the efforts that culminated in the development of Rotavac, a vaccine from Bharat Biotech that targets diarrhea.
Kang and one of her students subsequently established vaccine assays for rotavirus infections, used in testing Rotavac.
[17] Kang is the second Indian woman scientist to be elected a Fellow of the Royal Society (FRS) in 359 years of history of this scientific academy.